[1] Wen N, Cai Y, Li F, et al. The clinical management of hepatocellular carcinoma worldwide: A concise review and comparison of current guidelines: 2022 update. Biosci Trends,2022,16(1):20-30. [2] Wu X, Li J, Gassa A, et al. Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma. Int J Biol Sci,2020,16(9):1551-1562. [3] Voizard N, Ni T, Kiss A, et al. Small particle DEBIRI TACE as salvage therapy in patients with liver dominant colorectal cancer metastasis: Retrospective analysis of safety and outcomes. Curr Oncol,2022,29(1):209-220. [4] 谢慧, 王亮亮, 江凯,等. 多层螺旋CT与高场强磁共振LAVA增强对乙型肝炎肝硬化背景小肝癌的诊断价值对比.肝脏,2022,27(8):895-897. [5] Sun J, Wang Q, Hong ZX, et al. Stereotactic body radiotherapy versus hepatic resection for hepatocellular carcinoma (≤ 5 cm): a propensity score analysis. Hepatol Int,2020,14(5):788-797. [6] Pang Y, Zhao L, Meng T, et al. PET imaging of fibroblast activation protein in various types of cancer using 68Ga-FAP-2286: comparison with18F-FDG and 68Ga-FAPI-46 in a single-center, Prospective Study. J Nucl Med,2023,64(3):386-394. [7] 李博,张天宇,王浩,等.DWI联合DEC-MRI技术与CT多期动态增强及MPR重建对乙肝肝硬化背景下小肝癌诊断的对比研究.影像研究与医学应用,2020,4(16):60-62. [8] Son JH, Lee Y, Lee HJ, et al. LAVA HyperSense and deep-learning reconstruction for near-isotropic (3D) enhanced magnetic resonance enterography in patients with Crohn's disease: utility in noise reduction and image quality improvement. Diagn Interv Radiol,2023,29(3):437-449. [9] 杨莉月,杨晓亮,殷慧康,等. MRI Dual Lava动脉早晚期结合门脉期增强扫描技术在诊断肝癌中的应用.肝脏,2023,28(6):673-675,e679. [10] 施莹, 柏根基, 孙阳,等. 多模态MRI对肝硬化增生性结节与小肝癌的鉴别诊断价值探讨.实用肝脏病杂志,2022,25(5):722-725. [11] Zhang X, Wang Z, Tang W, et al. Ultrasensitive and affordable assay for early detection of primary liver cancer using plasma cell-free DNA fragmentomics. Hepatology, 2022,76(2):317-329. [12] Li B, Xia Y, Lyu J, et al. miR-151a-3p-rich small extracellular vesicles derived from gastric cancer accelerate liver metastasis via initiating a hepatic stemness-enhancing niche. Oncogene,2021,40(43):6180-6194. [13] Luo Y, Yue W, Li Z, et al. Contrast-enhanced ultrasound and its differential diagnosis in 21 patients with intrahepatic space-occupying lesions under the background of fatty liver. Ann Palliat Med,2021,10(3):3097-3104. [14] Li XL, Han PF, Wang W, et al. Multi-slice spiral computed tomography in differential diagnosis of gastric stromal tumors and benign gastric polyps, and gastric stromal tumor risk stratification assessment. World J Gastrointest Oncol,2022,14(10):2004-2013. [15] Ichikawa S, Motosugi U, Sato K, et al. Transient respiratory-motion artifact and scan timing during the arterial phase of gadoxetate disodium-enhanced MR imaging: The benefit of shortened acquisition and multiple arterial Phase acquisition. Magn Reson Med Sci,2021,20(3):280-289. [16] 田玉亭,李代欣,付志浩,等. 钆塞酸二钠磁共振成像表观弥散系数值联合最大强化率鉴别肝硬化背景下不典型增生结节与小肝癌.中国肝脏病杂志:电子版,2020,12(4):17-22. [17] Wei Y, Chen G, Tang H, et al. Improved display of hepatic arterial anatomy using differential subsampling with cartesian ordering (DISCO) with gadoxetic acid-enhanced MRI: comparison with single arterial phase MRI and computed tomographic angiography. J Magn Reson Imaging,2020,51(6):1766-1776. [18] Meng XP, Wang YC, Zhou JY, et al. Comparison of MRI and CT for theprediction of microvascular invasion in solitary hepatocellular carcinoma based on a non-radiomics and radiomics method: Which imaging modality is better. J Magn Reson Imaging,2021,54(2):526-536. [19] Oestmann PM, Wang CJ, Savic LJ, et al. Deep learning-assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non-HCC on contrast-enhanced MRI of the liver. Eur Radiol,2021,31(7):4981-4990. [20] Toshimori W, Matsuda M, Tsuda T, et al. Comparisons of hepatobiliary phase imaging using combinations of parallel imaging and variable degrees of compressed sensing with use of parallel imaging alone. J Comput Assist Tomogr,2023,47(4):524-529. |